User profiles for "author:Bernard A Fox"

Bernard A. Fox

Harder Family Chair for Cancer Research, Member and Chief, Molecular & Tumor …
Verified email at providence.org
Cited by 18145

Towards the introduction of the 'Immunoscore'in the classification of malignant tumours

J Galon, B Mlecnik, G Bindea, HK Angell… - The Journal of …, 2014 - Wiley Online Library
Abstract The American Joint Committee on Cancer/Union Internationale Contre le Cancer
(AJCC/UICC) TNM staging system provides the most reliable guidelines for the routine …

[HTML][HTML] Cancer classification using the Immunoscore: a worldwide task force

J Galon, F Pagès, FM Marincola, HK Angell… - Journal of translational …, 2012 - Springer
Prediction of clinical outcome in cancer is usually achieved by histopathological evaluation
of tissue samples obtained during surgical resection of the primary tumor. Traditional tumor …

Cancer and inflammation: promise for biologic therapy

S Demaria, E Pikarsky, M Karin… - Journal of …, 2010 - journals.lww.com
Cancers often arise as the end stage of inflammation in adults, but not in children. As such
there is a complex interplay between host immune cells during neoplastic development, with …

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

F Pagès, B Mlecnik, F Marliot, G Bindea, FS Ou… - The Lancet, 2018 - thelancet.com
Background The estimation of risk of recurrence for patients with colon carcinoma must be
improved. A robust immune score quantification is needed to introduce immune parameters …

[HTML][HTML] Neoantigen T-cell receptor gene therapy in pancreatic cancer

R Leidner, N Sanjuan Silva, H Huang… - … England Journal of …, 2022 - Mass Medical Soc
A patient with progressive metastatic pancreatic cancer was treated with a single infusion of
16.2× 109 autologous T cells that had been genetically engineered to clonally express two …

Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans.

GJ Nabel, EG Nabel, ZY Yang, BA Fox… - Proceedings of the …, 1993 - National Acad Sciences
Direct gene transfer offers the potential to introduce DNA encoding therapeutic proteins to
treat human disease. Previously, gene transfer in humans has been achieved by a cell …

[HTML][HTML] Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors

T Duhen, R Duhen, R Montler, J Moses… - Nature …, 2018 - nature.com
Identifying tumor antigen-specific T cells from cancer patients has important implications for
immunotherapy diagnostics and therapeutics. Here, we show that CD103+ CD39+ tumor …

[HTML][HTML] The immune score as a new possible approach for the classification of cancer

J Galon, F Pagès, FM Marincola, M Thurin… - Journal of translational …, 2012 - Springer
The outcome prediction in cancer is usually achieved by evaluating tissue samples obtained
during surgical removal of the primary tumor focusing on their histopathological …

OX40 is a potent immune-stimulating target in late-stage cancer patients

BD Curti, M Kovacsovics-Bankowski, N Morris… - Cancer research, 2013 - AACR
OX40 is a potent costimulatory receptor that can potentiate T-cell receptor signaling on the
surface of T lymphocytes, leading to their activation by a specifically recognized antigen. In …

[HTML][HTML] Multicenter international society for immunotherapy of cancer study of the consensus immunoscore for the prediction of survival and response to …

B Mlecnik, C Bifulco, G Bindea, F Marliot… - Journal of Clinical …, 2020 - ncbi.nlm.nih.gov
PURPOSE The purpose of this study was to evaluate the prognostic value of Immunoscore
in patients with stage III colon cancer (CC) and to analyze its association with the effect of …